# Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER)

> **NCT05922033** · PHASE4 · COMPLETED · sponsor: **Ohio State University** · enrollment: 56 (actual)

## Conditions studied

- Gestational Diabetes Mellitus
- Pregnancy in Diabetic
- Pregnancy, High Risk

## Interventions

- **DRUG:** Patient-led Insulin (intervention group)
- **DRUG:** Provider-led Insulin (standard care)

## Key facts

- **NCT ID:** NCT05922033
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-19
- **Primary completion:** 2025-03-30
- **Final completion:** 2025-05-01
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2025-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05922033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05922033, "Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05922033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*